BrainSleepImmuneSubcutaneous

Selank

10mg Vial

Typical Dose

250–500 mcg

Frequency

1–2x daily

Half-Life

Several minutes (active metabolites persist longer)

Research-use dosing; specific study population not established.

Selank Overview

Mechanism of Action

Selank is a synthetic analog of the naturally occurring immunomodulatory peptide Tuftsin (Thr-Lys-Pro-Arg) with an added Gly-Pro sequence for enhanced stability. It modulates the expression of brain-derived neurotrophic factor (BDNF) and serotonin, producing anxiolytic effects comparable to benzodiazepines without sedation or dependence. Additionally, it enhances IL-6 expression and influences the balance of T-helper cell cytokines.

Half-Life

Several minutes (active metabolites persist longer)

Timing

Morning or as needed for anxiety

Injection Site

Subcutaneous or intranasal

Food

No restrictions

Common Stacks

  • Semax — Complementary cognitive + immune support
  • BPC-157 — Combined anxiolytic and gut-healing effects

Selank Dosing Protocol

Standard Protocol

2–4 weeks

250–500 mcg daily

Subcutaneous or intranasal. Cycle 2 weeks on, 2 weeks off.

Acute Stress Protocol

1–2 weeks

500 mcg 2x/day

Higher frequency for acute anxiety. Taper to once daily.

Selank Expected Timeline

Day 1–3

Subtle anxiolytic effect; improved mental clarity

Week 1–2

Noticeable reduction in anxiety; stabilized mood

Week 2–4

Enhanced cognitive function; improved stress resilience

Selank Side Effects

Mild fatigue (uncommon)

Very well tolerated overall

No dependency or withdrawal reported

Selank Research Studies

Anxiolytic-like action of the hexapeptide selank in the elevated plus-maze

Seredenin SB, Kozlovskaia MM, Blednov YuA, et al. — Zh Vyssh Nerv Deiat Im I P Pavlova (1998)

Demonstrated selank produced significant anxiolytic effects in animal models comparable to benzodiazepines without the sedative or amnestic side effects.

PubMed: 9783152

Selank in the therapy of anxiety-phobic disorders

Zozulya AA, Sizov SV, Seredenin SB — Zh Nevrol Psikhiatr Im S S Korsakova (2008)

Clinical study showing selank significantly reduced anxiety scores in patients with generalized anxiety disorder over a 14-day treatment period.

PubMed: 18833097

Selank FAQ

Is selank habit-forming?

No. Unlike benzodiazepines, selank does not act on GABA-A receptors and has shown no evidence of tolerance, dependence, or withdrawal in clinical studies. Its anxiolytic effects work through BDNF and serotonin modulation.

Can selank be taken intranasally?

Yes. Selank is commonly administered both subcutaneously and intranasally. Intranasal delivery provides rapid onset of anxiolytic effects due to direct access to the CNS via the olfactory pathway.

Related Protocols